BackAl-Razi Medical Overview

Al-Razi Medical EBIT

Al-Razi Medical's EBIT is $3.5M, below the sector sector average of $2.3T.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

$749.89K
↑ 24.59% YoY

As of Jun 30, 2026

Annual EBIT (TTM)

$3.46M
↑ 38.19% YoY

Trailing 12 months ending Jun 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Al-Razi Medical (9572.SR) FAQ

As of the most recent data (June 2026), 9572.SR shows a EBIT of $3.5M. That compares with $2.5M in the prior-year period — up 38.2% year over year. That is below the sector sector average of $2.3T. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 9572.SR's EBIT is now $3.5M (was $2.5M) — a 38.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Al-Razi Medical is outperforming or lagging.

The its sector sector average EBIT is about $2.3T. Al-Razi Medical is at $3.5M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how 9572.SR stacks up against individual peers as well.

Tracking 9572.SR's ebit over time shows whether Al-Razi Medical is scaling, shrinking, or reshaping that part of the business. The current reading is $3.5M That compares with $2.5M in the prior-year period — up 38.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Al-Razi Medical's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $3.5M) with ownership activity and broader fundamentals.

Questions & Answers